Hepatocellular Cancer

This page contains recent news articles, when available, and an overview of Hepatocellular Cancer but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Background information on Hepatocellular Cancer

Hepatocellular carcinoma (HCC, also called hepatoma or liver cancer) is a primary malignancy (cancer) of the liver. Most cases of HCC are secondary to either hepatitis infection (usually hepatitis B or C) or cirrhosis (alcoholism being the most common cause of hepatic cirrhosis). In countries where hepatitis is not endemic, most cancers in the liver are not primary HCC but metastasis (spread) of cancer from elsewhere in the body, e.g. the colon. Treatment options of HCC and prognosis are dependent on many factors but especially on tumor size and staging.

In Sub-Saharan Africa and most other Third World countries the commonly accepted prognosis is a median survival of 3 months from diagnosis. This is partially due to late presentation with large tumours, but also the lack of medical expertise and facilities.

News Articles on Hepatocellular Cancer

Liver Cancer – Signs and Symptoms of Liver Cancer  -  Mar 17, 2008
Los Angeles Chronicle,Thus, the majority of primary liver cancers (over 90 to 95%) arises from liver cells and is called hepatocellular cancer or carcinoma.

Pfizer at Cowen and Company Health Care Conference - Final  -  Mar 24, 2008
Insurance News Net (press release),...situations that where we need to develop our drugs for gastric cancer, for hepatic cancer -- primary hepatocellular cancer and nasopharyngeal cancer.

ntists identify family of liver cancer genes  -  Mar 1, 2008
Thaindian.com,Washington, Mar 2 (ANI): A new study on mice, conducted by an interdisciplinary team of researchers at Stony Brook University Medical Center, has reported

Eisai Enters Into In-licensing Agreement with Minophagen ...  -  Dec 18, 2007
PharmaLive.com (press release),The results of these efforts have led to the introduction of the PIVKA-II series, a diagnosis product for hepatocellular cancer in 1989, which has been

full text  -  Nov 22, 2007
Science Magazine (subscription)93, 1495 (2006). the contributions of sex steroid dysregulation to the development of hepatocellular cancer (hcc) has been debated for decades,

fda approves bayer's nexavar for liver cancer  -  Nov 19, 2007
eFluxMedia...by alice turner the us food and drug administration has approved a previously "fast track"-designated drug for treatment of advanced hepatocellular

vaxon biotech receives european orphan medicinal product ...  -  Nov 21, 2007
Checkbiotech.org (press release),...two product candidates are in clinical development: vx-001 is pursuing phase ii studies in non-small cell lung cancer (nsclc) and hepatocellular cancer,

northwestern university and acorn commence national enrollment for ...  -  Nov 12, 2007
Earthtimes,...researchers are studying nexavar in pivotal trials in hepatocellular cancer, metastatic melanoma and non-small cell lung cancer. northwestern university

A Tumor Marker Ca 19-9 In Diabetics Can Lead To Misdiagnosis Of ...  -  Oct 15, 2007
Science Daily (press release)...ovarian cancer, hepatocellular cancer, colorectal cancer, inflammatory conditions of the hepatobiliary system, and in thyroid diseases.

Eloxatin® and Xeloda® for Treatment of Advanced Hepatocellular ...  -  Oct 10, 2007
Cancer Consultants (press release),Researchers from France have reported that the combination of Eloxatin (oxaliplatin) and Xeloda (Xelox®, capecitabine) is effective for the treatment of

Drinking More Coffee May Decrease Risk of Renal and Hepatocellular ...  -  Aug 10, 2007
Cancer Consultants (press release),Pooled data from 13 prospective studies have shown that increased intake of coffee and tea appears to decrease the risk of developing renal cell carcinoma

Pitt reaps $3.1 million in new funding for innovative research  -  Sep 4, 2007
Pop City,Beta-catenin is a key protein and researchers believe it is related to the development of hepatocellular cancer, the most common form of liver cancer.

Cytokinetics, Incorporated Reports Second Quarter 2007 Financial ...  -  Jul 31, 2007
CNNMoney.comIn Stage 1 of a two-stage designed Phase II clinical trial for the treatment of hepatocellular cancer, 15 patients received ispinesib as monotherapy at 18

Cytokinetics' Cancer Bid Iffy, Heart Effort Showing Promise  -  07 Jul 2007
BioWorld Online,But three separate Phase II studies sponsored by the National Cancer Institute in melanoma, hepatocellular cancer and hormone-resistant prostate cancer did

Cytokinetics Announces Data From Phase II Clinical Trial of ...  -  Jun 29, 2007
CNNMoney.comData are expected from the hepatocellular cancer, the prostate cancer and the melanoma trials in 2007. Data from the other ispinesib clinical trials have

Cytokinetics Reports Additional Clinical Trials Data for Ispinesib  -  Jun 29, 2007
CNNMoney.com...one in patients with hepatocellular cancer, one in patients with melanoma, and one in patients with hormone-refractory prostate cancer.

Cytokinetics Announces the Presentation of Clinical Trials Data at ...  -  05 Jun 2007
PipelineReview.com (press release),Data are expected from the hepatocellular cancer, the prostate cancer, the melanoma and the renal cell cancer trials in 2007. Data from the other ispinesib

Analysis: Bayer drug aids in liver cancer  -  Jun 4, 2007
United Press International...the compelling study results of Nexavar as the new reference standard of care for the first-line treatment of hepatocellular cancer," Llovet said.

Cytokinetics Announces Clinical Trials Data to Be Presented at the ...  -  May 18, 2007
Genetic Engineering News (press release),Data are expected from the hepatocellular cancer, the prostate cancer, the melanoma, and the renal cell cancer trials in 2007. Data from the other ispinesib

Blood DNA Can Be Early Predictor Of Liver Cancer Reported By ...  -  Apr 19, 2007
Medical News Today (press release),..."We are not only very excited about what this means in terms of early detection for hepatocellular cancer but optimistic about how it could also be applied

Cytokinetics, Incorporated Reports First Quarter 2007 Financial ...  -  Apr 26, 2007
Market Wire (press release)...trial in patients with hormone-refractory prostate cancer and from Stage 1 of the NCI's Phase II clinical trial in patients with hepatocellular cancer.

Adherex Outlines Corporate Goals for 2007  -  Mar 13, 2007
Genetic Engineering News (press release),Conclude the Phase I portion of the ongoing Phase I/II trial of eniluracil +5-FU in hepatocellular cancer in Asian patients by the third quarter of 2007 and

Cytokinetics, Incorporated Reports Fourth Quarter and Year End ...  -  Jan 31, 2007
Earthtimes.orgAll patients are now off study drug in the prostate cancer and hepatocellular cancer trials. While enrollment is complete, patients remain on study drug in

Cytokinetics Announces Initiation Of Phase II Clinical Trial In ...  -  Dec 24, 2006
Haber Sağlık,Data are expected from the hepatocellular cancer clinical trial, the prostate cancer clinical trial and the melanoma clinical trial in the first half of

Positive Results For Liver Cancer Trial  -  Dec 24, 2006
Medical News Today (press release),Liver cancer (or hepatocellular cancer) is the fourth most common cancer in the world and one of the most deadly, killing most patients within a year.

BioAlliance Pharma Announces Phase II/III Trial for Its Primary ...  -  Dec 15, 2006
PipelineReview.com (press release),PARIS, France | Dec 14, 2006 | BioAlliance Pharma SA , an emerging specialty pharmaceutical company, announced today that it has received approval from

BioAlliance Pharma announces Phase II/III trial for its primary ...  -  Dec 14, 2006
Capital.fr,Paris, December 14, 2006 -- BioAlliance Pharma SA (Euronext Paris – Code Isin: FR0010095596 - BIO), an emerging specialty pharmaceutical company,

Positive Results for Liver Cancer Trial  -  Dec 13, 2006
PharmaLive.com (press release),BRISBANE, Australia, December 13, 2006 /PRNewswire-FirstCall/ -- Liver cancer (or hepatocellular cancer) is the fourth most common cancer in the world and

Positive resultc for liver cancer trial  -  Dec 13, 2006
Antara (press release),Brisbane (ANTARA News/PRNewswire-AsiaNet) - Liver cancer (or hepatocellular cancer) is the fourth most common cancer in the world and one of the most deadly

Cytokinetics Announces Non-Clinical Poster Presentation Regarding ...  -  Dec 11, 2006
PR Newswire (press release),...in the first-line treatment of patients with hepatocellular cancer, in the first- line treatment of patients with melanoma, in the first-line or

Positive Results for Liver Cancer Trial  -  13 Dec 2006
Yahoo! News (press release)13 /PRNewswire-FirstCall/ -- Liver cancer (or hepatocellular cancer) is the fourth most common cancer in the world and one of the most deadly, killing most ...

CuraGen and TopoTarget Provide Update and Preliminary Data on ...  -  Oct 26, 2006
Earthtimes.orgPXD101 for the treatment of mesothelioma; * A Phase I/II clinical trial evaluating PXD101 for the treatment of inoperable hepatocellular cancer; * A Phase I ...

Cytokinetics, Incorporated Reports Third Quarter 2006 Financial ...  -  Oct 26, 2006
PR Newswire (press release),The National Cancer Institute (NCI) continued to treat patients in a Phase II clinical trial of ispinesib in patients with hepatocellular cancer, and also ...

Search the web for more resources on Hepatocellular Cancer

Web health.mongabay.com

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.